# Sex differences in AMPA receptor trafficking proteins

**Authors:** Mia Y. Roberts, Lisa A. Briand

PMC · DOI: 10.1186/s13293-026-00849-1 · Biology of Sex Differences · 2026-02-13

## TL;DR

This paper reviews how sex differences may affect proteins involved in AMPA receptor trafficking, which is important for brain function and psychiatric diseases.

## Contribution

The paper highlights the lack of sex-based research in glutamate receptor trafficking and suggests the need to study sex differences for better disease understanding.

## Key findings

- Most studies on AMPA receptor trafficking proteins have used male animals or cell cultures.
- Sex differences in these proteins may impact psychiatric diseases differently in males and females.
- Current understanding of glutamate trafficking may not apply equally to both sexes.

## Abstract

AMPA receptors are a type of ionotropic glutamate receptor that is important for fast excitatory neurotransmission. healthy brain function. Glutamate signaling is regulated, in part, by the trafficking of glutamate receptors in and out of the synapse. Multiple different trafficking and auxiliary proteins govern this process. Disruptions in this trafficking are linked to various psychiatric diseases, including schizophrenia, major depressive disorder. Glutamate, the primary excitatory neurotransmitter, is crucial for synaptic plasticity and and substance use disorder. Moreover, the incidence and symptomology of these psychiatric diseases impact males and females differently. Despite these epidemiological sex differences, very little research has considered the influence of biological sex on glutamatergic trafficking. Here, we review the current literature on glutamate trafficking proteins for AMPA receptors, most of which have mainly utilized male rodents and cell cultures. The following proteins were explored for AMPA receptors: GRIP, PICK1, NSF, SAP97, AKAP79/150, Protein 4.1 N, and PSD-95. Overall, these studies revealed that our fundamental understanding of glutamate trafficking is based almost completely on studies performed in male animals, and the assumption that the same mechanisms govern AMPAR trafficking in females may not be correct. To fully grasp how these proteins are impacted in disease models, it’s crucial to first understand the baseline sex differences. This is especially important if we want to investigate new research avenues for treating diseases that affect each sex differently.

## Linked entities

- **Proteins:** GRIP1 (glutamate receptor interacting protein 1), PICK1 (protein interacting with PRKCA 1), NSF (N-ethylmaleimide sensitive factor, vesicle fusing ATPase), DLG1 (discs large MAGUK scaffold protein 1), DLG4 (discs large MAGUK scaffold protein 4)
- **Diseases:** schizophrenia (MONDO:0005090), major depressive disorder (MONDO:0002009)

## Full-text entities

- **Genes:** DLG1 (discs large MAGUK scaffold protein 1) [NCBI Gene 1739] {aka DLGH1, SAP-97, SAP97, hdlg}, DLG4 (discs large MAGUK scaffold protein 4) [NCBI Gene 1742] {aka MRD62, PSD95, SAP-90, SAP90}, PICK1 (protein interacting with PRKCA 1) [NCBI Gene 9463] {aka PICK, PRKCABP}, NSF (N-ethylmaleimide sensitive factor, vesicle fusing ATPase) [NCBI Gene 4905] {aka DEE96, SEC18, SKD2}, GRIP1 (glutamate receptor interacting protein 1) [NCBI Gene 23426] {aka FRASRS3, GRIP}
- **Diseases:** substance use disorder (MESH:D019966), major depressive disorder (MESH:D003865), schizophrenia (MESH:D012559), psychiatric diseases (MESH:D001523)
- **Chemicals:** Glutamate (MESH:D018698)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13005412/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13005412/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC13005412/full.md

---
Source: https://tomesphere.com/paper/PMC13005412